arrow
F

Francesca Corti

fondazione irccs istituto nazionale tumori milan
H指数:28
被引数:2,493

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2

二甲双胍联合兰瑞肽治疗晚期胃肠道或肺神经内分泌肿瘤的安全性和抗肿瘤活性: Ib期试验MetNET2

2023-12-140
OAAI
Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial

评估卡博替尼联合兰瑞肽在胃肠胰腺和胸部神经内分泌肿瘤中的安全性和活性: II期LOLA试验的原理和方案

2023-09-266
OAAI
Comparative analysis of wild-type and chloroplast MCU-deficient plants reveals multiple consequences of chloroplast calcium handling under drought stress

野生型和叶绿体MCU缺陷型植物的比较分析揭示了干旱胁迫下叶绿体钙处理的多种后果

2023-08-251
OAAI
Tumour mutational burden as a biomarker in patients with mismatch repair deficient/microsatellite instability- high metastatic colorectal cancer treated with immune checkpoint inhibitors

错配修复缺陷/微卫星不稳定的高转移性结直肠癌患者接受免疫检查点抑制剂治疗的肿瘤突变负荷作为生物标志物

2023-07-0114
PRE
Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancer
2022-09-0117
PRE
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers
2022-06-135
OA
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?

FOLFOXIRI和贝伐单抗在BRAFV600E-mutated转移性结直肠癌患者中的先期获益: 原发肿瘤位置重要吗?

2022-06-039
OA
Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future Perspective
2022-02-048
OAAI
Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino study
2021-11-2219
OA
Circulating tumor DNA variant allelic fraction as a surrogate for disease burden estimation in patients with RAS wild-type metastatic colorectal cancer: A secondary endpoint of the VALENTINO study
2021-07-012
PREAI
The Pan-Immune-Inflammation Value in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitors

免疫检查点抑制剂治疗的微卫星不稳定性高转移性结直肠癌患者的泛免疫炎症价值

2021-06-0163
PRE